Axonics, Inc.
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and u…
Medical - Devices
US, Irvine [HQ]
AXNX/Financial Reporting
Income Statements
8 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | - - | - - | - - | 13.00 | 111.00 | 180.00 | 273.00 | 366.00 | |
|
EPS
|
-0.95 | -0.97 | -4.64 | -2.80 | -1.48 | -1.86 | -1.28 | -0.12 | |
| Diluted in mil. | -0.95 | -0.97 | -4.64 | -2.80 | -1.48 | -1.86 | -1.28 | -0.12 | |
|
Profit
|
- - | - - | - - | 7.00 | 67.00 | 115.00 | 197.00 | 265.00 | |
| Gross Margin | - - | 7.94 | 49.65 | 53.04 | 60.15 | 64.18 | 72.22 | 72.46 | |
| Pre Tax | -17.00 | -18.00 | -32.00 | -79.00 | -54.00 | -79.00 | -62.00 | -8.00 | |
| Profit Margin | - - | -14,097.05 | -4,594.34 | -578.39 | -49.23 | -43.98 | -22.77 | -2.39 | |
| ETR | - - | 0.12 | - - | - - | - - | -0.99 | 4.20 | 30.38 | |
| Net | -17.00 | -18.00 | -32.00 | -79.00 | -54.00 | -80.00 | -59.00 | -6.00 | |
| Profit Margin | - - | -14,097.05 | -4,594.48 | -578.40 | -49.24 | -44.41 | -21.81 | -1.66 | |
| EBITDA | -16.00 | -17.00 | -31.00 | -77.00 | -52.00 | -60.00 | -27.00 | 8.00 | |
| EBITDA Margin | - - | -13,479.81 | -4,404.38 | -561.69 | -47.52 | -33.34 | -10.18 | 2.37 | |
| Operating Income | -17.00 | -18.00 | -32.00 | -80.00 | -53.00 | -67.00 | -42.00 | -4.00 | |
| Operating Margin | - - | -14,185.62 | -4,545.54 | -583.21 | -48.20 | -37.38 | -15.49 | -1.29 | |
| Interest Income | - - | - - | - - | 2.00 | - - | - - | 5.00 | 16.00 | |
| Loss | -17.00 | -18.00 | -32.00 | -94.00 | -165.00 | -247.00 | -316.00 | -371.00 | |
| Cost of Revenue | - - | - - | - - | -6.00 | -44.00 | -64.00 | -76.00 | -100.00 | |
|
Operating Expenses
|
-17.00 | -18.00 | -32.00 | -87.00 | -120.00 | -183.00 | -240.00 | -270.00 | |
| R&D | -12.00 | -12.00 | -19.00 | -20.00 | -29.00 | -37.00 | -34.00 | -34.00 | |
| G&A | -4.00 | -4.00 | -9.00 | -19.00 | -25.00 | -32.00 | -40.00 | -45.00 | |
| SG&A | -4.00 | -5.00 | -13.00 | -67.00 | -91.00 | -138.00 | -196.00 | -235.00 | |
| S&M | - - | -1.00 | -3.00 | -48.00 | -66.00 | -105.00 | -156.00 | -189.00 | |
| Depreciation and Amortization | - - | - - | - - | -1.00 | -1.00 | -9.00 | -11.00 | -13.00 | |
| Interest Expenses | - - | - - | -1.00 | -2.00 | -1.00 | -7.00 | -2.00 | - - | |
| Other Expenses | - - | - - | - - | - - | -1.00 | -11.00 | -19.00 | -4.00 | |
|
WA Shares Outstanding
|
18.00 | 18.00 | 6.00 | 28.00 | 36.00 | 43.00 | 46.00 | 49.00 | |
| Diluted | 18.00 | 18.00 | 6.00 | 28.00 | 36.00 | 43.00 | 46.00 | 49.00 |